Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$39.16+1.48 (+3.93%)
Close on Nov 18, 2026Market cap $51.48BP/E –Yield –
Medline operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Medline's operating income for the twelve months ending Sep 26, 2026 was $1.74B. For fiscal 2025 it was $2.21B, up 3.1% from the year before.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.21B | +3.1% |
| FY2024 | Dec 31, 2024 | $2.15B | +71.7% |
| FY2023 | Dec 31, 2023 | $1.25B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $500.00M | -12.9% |
| Q2 FY2026 | Jun 27, 2026 | $395.00M | -38.5% |
| Q1 FY2026 | Mar 28, 2026 | $422.00M | -26.1% |
| Q4 FY2025 | Dec 31, 2025 | $425.00M | – |
| Q3 FY2025 | Sep 27, 2025 | $574.00M | – |
| Q2 FY2025 | Jun 28, 2025 | $642.00M | – |
| Q1 FY2025 | Mar 29, 2025 | $571.00M | – |
See a number that looks wrong?